Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

RVP stock opened at $0.64 on Friday. The firm has a 50 day simple moving average of $0.69 and a two-hundred day simple moving average of $0.91. The stock has a market cap of $19.01 million, a PE ratio of -1.18 and a beta of 1.98. Retractable Technologies has a one year low of $0.56 and a one year high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Insider Activity at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw purchased 71,422 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. The trade was a 0.49 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders bought 176,995 shares of company stock worth $132,936 in the last three months. 54.60% of the stock is owned by insiders.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.